×
The Natural History of Psychosis and Depression in Dementia With Lewy Bodies and Alzheimer's Disease: Persistence and New Cases Over 1 Year of Follow-Up PDF
$ 40.00
The Natural History of Psychosis and Depression in Dementia With Lewy Bodies and Alzheimer's Disease: Persistence and New Cases Over 1 Year of Follow-Up PDF quantity
$ 40.00
×
Perceptions and Impact of Bipolar Disorder: How Far Have We Really Come? Results of the National Depressive and Manic-Depressive Association 2000 Survey of Individuals With Bipolar Disorder PDF
$ 40.00
Perceptions and Impact of Bipolar Disorder: How Far Have We Really Come? Results of the National Depressive and Manic-Depressive Association 2000 Survey of Individuals With Bipolar Disorder PDF quantity
$ 40.00
×
A Double-Blind, Placebo-Controlled Trial of the Safety and Efficacy of Selegiline Transdermal System Without Dietary Restrictions in Patients With Major Depressive Disorder PDF
$ 40.00
A Double-Blind, Placebo-Controlled Trial of the Safety and Efficacy of Selegiline Transdermal System Without Dietary Restrictions in Patients With Major Depressive Disorder PDF quantity
$ 40.00
×
The Maudsley Bipolar Disorder Project: The Effect of Medication, Family History, and Duration of Illness on IQ and Memory in Bipolar I Disorder PDF
$ 40.00
The Maudsley Bipolar Disorder Project: The Effect of Medication, Family History, and Duration of Illness on IQ and Memory in Bipolar I Disorder PDF quantity
$ 40.00
×
Aromatherapy as a Safe and Effective Treatment for the Management of Agitation in Severe Dementia: The Results of a Double-Blind, Placebo-Controlled Trial With Melissa PDF
$ 40.00
Aromatherapy as a Safe and Effective Treatment for the Management of Agitation in Severe Dementia: The Results of a Double-Blind, Placebo-Controlled Trial With Melissa PDF quantity
$ 40.00
×
A 3-Month, Randomized, Placebo-Controlled, Neuroleptic Discontinuation Study in 100 People With Dementia: The Neuropsychiatric Inventory Median Cutoff Is a Predictor of Clinical Outcome PDF
$ 40.00
A 3-Month, Randomized, Placebo-Controlled, Neuroleptic Discontinuation Study in 100 People With Dementia: The Neuropsychiatric Inventory Median Cutoff Is a Predictor of Clinical Outcome PDF quantity
$ 40.00
Coupon: Apply coupon
Update cart
